View drug registration information details.

Items	Registration information
ID	28
No	28
Brand Name	ATORVIN 10
Ingredients	ATORVASTATIN CALCIUM 10.84 MG EQ.TO ATORVASTATIN 10 MG
Dosage Form	FILM COATED TABLET
Primary Packaging	ALU-ALU
Storage	STORE AT TEMPERATURE NOT MORE THAN 30 C
Shelf Life	2 YEARS
Pack Size	BOX OF 10 X 10'S
Dispensing Category	PRESCRIPTION ONLY
ATC Classification	C10AA05
Pharmaceutical Class	LIPID MODIFYING AGENT
Indications	AS AN ADJUNCT TO DIET FOR REDUCTION OF ELEVATED TOTAL CHOLESTEROL (TOTAL -C), LDL-CHOLESTEROL (LDL-C), APOLIPOPROTEIN B AND TRIGLYCERIDE IN ADULTS, ADOLESCENTS AND CHILDREN AGED 10 YEARS OR OLDER WITH PRIMARY HYPERCHOLESTEROLAEMIA OR COMBINED HYPERLIPIDAEMIA WHEN RESPONSE TO DIET AND OTHER NONPHARMACOLOGICAL MEASURES IS INADEQUATE. PREVENTION OF CARDIOVASCULAR EVENTS IN ADULT PATIENTS ESTIMATED TO HAVE A HIGH RISK FOR A FIRST CARDIOVASCULAR EVENT, AS AN ADJUNCT TO CORRECTION OF OTHRT RISK FACTORS
Contraindications	HYPERSENSITIVITY TO API OR EXCIPIENT, ACTIVE LIVER DISEASE, DURING PREGNANCY, WHILE BREAST-FEEDING , TREATED WITH HEPATITIS A ANTIVIRALS
Side Effects	NASOPHARYNGITIS, ALLERGIC REACTIONS, HYPERGLYCAEMIA, HEADACHE, PHARYNGOLARYNGEAL PAIN, CONSTIPATION,
Unit Price	1600B
EDL	Yes
Description	WHITE, ELLIPTICAL, BICONVEX, FILM COATED TABLET WITH ENGRAVED 10 ON ONE SIDE AND PLAIN ON THE OTHER
Note
License Owner	AI KEN PHARMA CO., LTD
Manufacturer	UNISON LABORATORIES CO., LTD
Country	THAILAND
Import Registration No	1A 39/61 (NG)
Import Registration Date	20/09/2018
Activity	CERTIFICATE RELEASED
Applied Date	2021-12-24
FDD Registration No	03 I 5424/23
FDD Registration Date	2023-03-31
Expiry Date	2026-03-30

Back to drug list